Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (symbol: ELV) is a prominent American health insurance provider, formerly known as Anthem, Inc. until June 2022. As one of the leading health insurers in the United States, Elevance Health delivers medical benefits to approximately 47 million members as of December 2023. The company’s core business revolves around offering a wide range of coverage plans, including employer, individual, and government-sponsored options.
One distinctive feature of Elevance Health is its status as the largest single provider of Blue Cross Blue Shield branded coverage. As the licensee for the Blue Cross Blue Shield Association in 14 states, the company serves a significant portion of the U.S. population. Elevance Health has successfully expanded its offerings through strategic acquisitions, such as the purchase of Amerigroup in 2012 and MMM in 2021. These acquisitions enable the company to broaden its reach and better serve populations enrolled in government-sponsored programs like Medicaid and Medicare Advantage plans.
Elevance Health is committed to improving healthcare accessibility and affordability. The company consistently works on enhancing its services and products to meet the evolving needs of its members. Financially, Elevance Health has maintained a strong position, reflecting robust performance and growth potential.
Recent achievements include the expansion of digital health initiatives and partnerships with healthcare providers to offer more integrated and comprehensive care solutions. With its extensive network and innovative approach, Elevance Health continues to make significant strides in the healthcare industry.
Stay updated with the latest news and developments related to Elevance Health to understand its impact and future direction in the health insurance market.
Elevance Health has announced a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana (BCBSLA). This acquisition aims to enhance community health services, leveraging Elevance's advanced healthcare capabilities. BCBSLA, serving over 1.9 million members, will continue to operate from Baton Rouge and maintain its local workforce of approximately 3,000 employees. The deal, expected to close later this year, will also establish the Accelerate Louisiana Initiative, a multibillion-dollar foundation focused on health equity. The acquisition is subject to customary closing conditions and regulatory approvals.
Elevance Health (NYSE: ELV) is set to release its fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. EST. A conference call will follow at 8:30 a.m. EST, where management will discuss the results and future outlook. Interested participants should access the call 15 minutes early, using specific phone numbers for domestic and international calls. The call will also be available via a live webcast on Elevance Health's website.
Elevance Health (NYSE: ELV) has earned full three-year accreditation for health equity from the National Committee for Quality Assurance (NCQA) for 21 of its affiliated Medicaid plans. This accreditation highlights the company's commitment to enhancing health equity and addressing the needs of historically marginalized communities. Currently, 93% of Elevance Health's Medicaid members are enrolled in accredited plans, representing a significant achievement in the industry. The company aims to innovate and improve care for diverse populations across the nation.
Elevance Health has partnered with Impact Fitness Foundation to enhance the fitness resources at Herron-Riverside High School in
The upgraded facility, unveiled on
Elevance Health announces its agreement to acquire BioPlus, a specialty pharmacy under CarepathRx, enhancing its specialty drug solutions for complex conditions like cancer and autoimmune diseases. This acquisition supports Elevance's whole-health strategy, aiming to improve access and reliability for clients. Post-acquisition, BioPlus will operate under IngenioRx, Elevance's pharmacy benefit manager. The deal is set to close in the first half of 2023, with no expected material impact on adjusted earnings per share this year.
Elevance Health (NYSE: ELV) will present at the 4th Annual Wolfe Research Healthcare Conference in New York City on November 16 at 10:00 a.m. EST. Stakeholders can access the live webcast by visiting Elevance Health’s website. A replay will be available for 90 days post-presentation. Elevance Health is dedicated to enhancing healthcare access for over 119 million individuals through its comprehensive portfolio of medical, digital, and behavioral health solutions.
The recent study commissioned by Elevance Health reveals that 94% of Americans who used virtual primary care are satisfied, with 79% feeling empowered about their health. Conducted by The Harris Poll, the survey of over 5,000 adults shows that convenience and accessibility are key attractions to virtual care. While 48% are familiar with the term, 73% find it appealing. Many Americans, especially those with chronic conditions, see it as a way to enhance healthcare access. The study confirms a significant rise in telehealth usage, nearly 20 times pre-pandemic levels.
Elevance Health (NYSE: ELV) will present at the 31st Annual Credit Suisse Healthcare Conference on November 9, at 11:35 a.m. PST in Rancho Palos Verdes, California. Interested individuals can access the live webcast via www.elevancehealth.com. A replay will be available for 90 days after the presentation. Elevance Health serves over 119 million people with a range of healthcare solutions, dedicated to improving health outcomes and supporting communities.
The Board of Directors of Elevance Health (NYSE: ELV) announced the appointment of Deanna Strable to the Board. With over 30 years in financial services, Strable is currently CFO of Principal Financial Group, responsible for financial integrity and growth. Her experience includes leading the U.S. Insurance Solutions division. Strable's appointment brings the board's female and diverse director representation to over 70%. Elizabeth Tallett, Board Chair, highlighted her proven expertise in the insurance sector and commitment to diversity.
Elevance Health reported strong third quarter 2022 results with a GAAP net income of $6.68 per share, adjusted net income at $7.53 per share, and operating revenue of $39.6 billion, up 11.5% year-over-year. Medical enrollment increased by 2.2 million to 47.3 million members. The company also declared a fourth quarter dividend of $1.28 per share. With a projected full-year GAAP net income exceeding $25.33 per share, Elevance demonstrates robust growth driven by strategic operations and increasing membership.
FAQ
What is the current stock price of Elevance Health (ELV)?
What is the market cap of Elevance Health (ELV)?
What does Elevance Health, Inc. do?
What was Elevance Health, Inc. previously known as?
How many members does Elevance Health serve?
What makes Elevance Health unique among its peers?
What major acquisitions has Elevance Health completed?
What types of health plans does Elevance Health offer?
How does Elevance Health contribute to improving healthcare?
What is the financial condition of Elevance Health?
What recent initiatives has Elevance Health undertaken?
How can I stay updated on Elevance Health's latest news?
